DE69837086T2 - Verbesserte prokariontische proteinenexpression - Google Patents
Verbesserte prokariontische proteinenexpression Download PDFInfo
- Publication number
- DE69837086T2 DE69837086T2 DE69837086T DE69837086T DE69837086T2 DE 69837086 T2 DE69837086 T2 DE 69837086T2 DE 69837086 T DE69837086 T DE 69837086T DE 69837086 T DE69837086 T DE 69837086T DE 69837086 T2 DE69837086 T2 DE 69837086T2
- Authority
- DE
- Germany
- Prior art keywords
- wpra
- gene
- strain
- subtilis
- wpra gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 94
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 61
- 230000014509 gene expression Effects 0.000 title claims abstract description 30
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 83
- 101150051250 wprA gene Proteins 0.000 claims abstract description 74
- 230000028327 secretion Effects 0.000 claims abstract description 23
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 21
- 229920001184 polypeptide Polymers 0.000 claims abstract description 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 20
- 230000001580 bacterial effect Effects 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 34
- 101100049732 Bacillus subtilis (strain 168) wprA gene Proteins 0.000 claims description 29
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 239000001963 growth medium Substances 0.000 claims description 23
- 238000012217 deletion Methods 0.000 claims description 21
- 230000037430 deletion Effects 0.000 claims description 21
- 108091005804 Peptidases Proteins 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 14
- 239000002243 precursor Substances 0.000 claims description 10
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 8
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 230000035772 mutation Effects 0.000 claims description 7
- 101500006588 Bacillus subtilis (strain 168) Cell wall-associated polypeptide CWBP52 Proteins 0.000 claims description 6
- 230000001939 inductive effect Effects 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 239000004382 Amylase Substances 0.000 claims description 4
- 102000013142 Amylases Human genes 0.000 claims description 4
- 108010065511 Amylases Proteins 0.000 claims description 4
- 241000194108 Bacillus licheniformis Species 0.000 claims description 4
- 101500006587 Bacillus subtilis (strain 168) Cell wall-associated polypeptide CWBP23 Proteins 0.000 claims description 4
- 235000019418 amylase Nutrition 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 3
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 3
- 108010059892 Cellulase Proteins 0.000 claims description 2
- 108090000371 Esterases Proteins 0.000 claims description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 2
- 102100022624 Glucoamylase Human genes 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 108090001060 Lipase Proteins 0.000 claims description 2
- 102000004882 Lipase Human genes 0.000 claims description 2
- 239000004367 Lipase Substances 0.000 claims description 2
- 102000004316 Oxidoreductases Human genes 0.000 claims description 2
- 108090000854 Oxidoreductases Proteins 0.000 claims description 2
- 108010089934 carbohydrase Proteins 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 229940106157 cellulase Drugs 0.000 claims description 2
- 235000019421 lipase Nutrition 0.000 claims description 2
- 101001094044 Mus musculus Solute carrier family 26 member 6 Proteins 0.000 claims 2
- 241000831652 Salinivibrio sharmensis Species 0.000 claims 1
- 230000001965 increasing effect Effects 0.000 abstract description 10
- 230000009465 prokaryotic expression Effects 0.000 abstract description 5
- 230000004075 alteration Effects 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 108090000637 alpha-Amylases Proteins 0.000 description 60
- 102000004139 alpha-Amylases Human genes 0.000 description 57
- 229940024171 alpha-amylase Drugs 0.000 description 57
- -1 AmyL Chemical class 0.000 description 47
- 239000013612 plasmid Substances 0.000 description 40
- 239000012634 fragment Substances 0.000 description 26
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 22
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 22
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 230000010354 integration Effects 0.000 description 14
- 210000000349 chromosome Anatomy 0.000 description 13
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 13
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 12
- 230000015556 catabolic process Effects 0.000 description 10
- 238000010276 construction Methods 0.000 description 10
- 238000006731 degradation reaction Methods 0.000 description 10
- 239000013598 vector Substances 0.000 description 10
- 229960003276 erythromycin Drugs 0.000 description 9
- 230000010076 replication Effects 0.000 description 8
- 244000063299 Bacillus subtilis Species 0.000 description 7
- 210000002421 cell wall Anatomy 0.000 description 7
- 101710089384 Extracellular protease Proteins 0.000 description 6
- 102000035195 Peptidases Human genes 0.000 description 6
- 102000012479 Serine Proteases Human genes 0.000 description 6
- 108010022999 Serine Proteases Proteins 0.000 description 6
- 101150007424 amyS gene Proteins 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 6
- 229960000268 spectinomycin Drugs 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000003155 DNA primer Substances 0.000 description 5
- 230000005526 G1 to G0 transition Effects 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 125000001475 halogen functional group Chemical group 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 101150038987 xylR gene Proteins 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 239000013615 primer Substances 0.000 description 4
- 230000017854 proteolysis Effects 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 230000003248 secreting effect Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 239000007160 ty medium Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 210000004900 c-terminal fragment Anatomy 0.000 description 3
- 239000013611 chromosomal DNA Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000001114 immunoprecipitation Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 230000005945 translocation Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108091058545 Secretory proteins Proteins 0.000 description 2
- 102000040739 Secretory proteins Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004898 n-terminal fragment Anatomy 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000007320 rich medium Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 101710088758 23kDa protein Proteins 0.000 description 1
- FFEARJCKVFRZRR-FOEKBKJKSA-N 3654-96-4 Chemical compound C[35S]CC[C@H](N)C(O)=O FFEARJCKVFRZRR-FOEKBKJKSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 101100449690 Bacillus licheniformis (strain ATCC 14580 / DSM 13 / JCM 2505 / CCUG 7422 / NBRC 12200 / NCIMB 9375 / NCTC 10341 / NRRL NRS-1264 / Gibson 46) blaSE gene Proteins 0.000 description 1
- 101100043757 Bacillus subtilis (strain 168) bpr gene Proteins 0.000 description 1
- 101100043755 Bacillus subtilis (strain 168) epr gene Proteins 0.000 description 1
- 101100238373 Bacillus subtilis (strain 168) mpr gene Proteins 0.000 description 1
- 101100460774 Bacillus subtilis (strain 168) nprB gene Proteins 0.000 description 1
- 101100275473 Caenorhabditis elegans ctc-3 gene Proteins 0.000 description 1
- 101100148606 Caenorhabditis elegans pst-1 gene Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 101710125870 Cell wall-associated protease Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 101710180012 Protease 7 Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108010020764 Transposases Proteins 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 101150009206 aprE gene Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000010310 bacterial transformation Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001609 comparable effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 101150112117 nprE gene Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000024540 transposon integration Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 108700026215 vpr Genes Proteins 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9708452.9A GB9708452D0 (en) | 1997-04-26 | 1997-04-26 | Improved prokaryotic expression of protein |
| GB9708452 | 1997-04-26 | ||
| PCT/GB1998/001051 WO1998049328A1 (en) | 1997-04-26 | 1998-04-24 | Improved prokaryotic expression of protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69837086D1 DE69837086D1 (de) | 2007-03-29 |
| DE69837086T2 true DE69837086T2 (de) | 2007-11-15 |
Family
ID=10811386
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69837086T Expired - Fee Related DE69837086T2 (de) | 1997-04-26 | 1998-04-24 | Verbesserte prokariontische proteinenexpression |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0977875B1 (https=) |
| JP (1) | JP4312834B2 (https=) |
| CN (1) | CN1142280C (https=) |
| AT (1) | ATE353971T1 (https=) |
| AU (1) | AU7057098A (https=) |
| DE (1) | DE69837086T2 (https=) |
| DK (1) | DK0977875T3 (https=) |
| GB (1) | GB9708452D0 (https=) |
| WO (1) | WO1998049328A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100411238B1 (ko) * | 2000-08-19 | 2003-12-18 | 한국과학기술원 | 외래 단백질을 안정하게 발현하는 바실러스 속 미생물 |
| US20050176097A1 (en) * | 2002-04-10 | 2005-08-11 | Andersen Jens T. | Bacillus host cell |
| ATE399869T1 (de) | 2002-04-10 | 2008-07-15 | Novozymes As | Verbesserte bacillus-wirtszelle |
| DK1735451T3 (da) | 2004-04-07 | 2010-03-08 | Novozymes As | Muteret prokaryot celle med høje secerneringsniveauer |
| JP4485341B2 (ja) | 2004-12-20 | 2010-06-23 | 花王株式会社 | 組換え微生物 |
| CN101321866B (zh) | 2005-10-13 | 2012-11-14 | 花王株式会社 | 新型枯草杆菌突变株 |
| WO2015181118A1 (en) | 2014-05-27 | 2015-12-03 | Novozymes A/S | Methods for producing lipases |
| KR102588719B1 (ko) * | 2014-12-16 | 2023-10-12 | 다니스코 유에스 인크. | 향상된 단백질 발현 |
| AU2018256925B2 (en) * | 2017-04-28 | 2024-11-21 | Agrospheres, Inc. | Compositions and methods for the encapsulation and scalable delivery of agrochemicals |
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| BR112020005803A2 (pt) | 2017-09-25 | 2020-12-01 | Agrospheres, Inc. | composições e métodos para produção e administração moduláveis de produtos biológicos |
| CN110592125B (zh) * | 2019-09-30 | 2023-09-01 | 南京农业大学 | 一种食品级降解乙醇枯草杆菌重组菌的构建方法 |
| CN113025601B (zh) * | 2019-12-25 | 2024-06-21 | 上海奥博生物医药股份有限公司 | 腈水解酶启动子优化表达及应用 |
| CN115948395A (zh) * | 2022-08-23 | 2023-04-11 | 南京农业大学 | 一种人工改造的木糖诱导型启动子及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2003078A1 (en) * | 1988-11-18 | 1990-05-18 | Biotechnica International, Inc. | Protease deletion |
| US5294542A (en) * | 1991-03-19 | 1994-03-15 | Omnigene, Inc. | Residual protease-III |
-
1997
- 1997-04-26 GB GBGB9708452.9A patent/GB9708452D0/en active Pending
-
1998
- 1998-04-24 AU AU70570/98A patent/AU7057098A/en not_active Abandoned
- 1998-04-24 CN CNB988045311A patent/CN1142280C/zh not_active Expired - Fee Related
- 1998-04-24 DE DE69837086T patent/DE69837086T2/de not_active Expired - Fee Related
- 1998-04-24 JP JP54669998A patent/JP4312834B2/ja not_active Expired - Fee Related
- 1998-04-24 EP EP98917325A patent/EP0977875B1/en not_active Revoked
- 1998-04-24 AT AT98917325T patent/ATE353971T1/de not_active IP Right Cessation
- 1998-04-24 DK DK98917325T patent/DK0977875T3/da active
- 1998-04-24 WO PCT/GB1998/001051 patent/WO1998049328A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69837086D1 (de) | 2007-03-29 |
| CN1142280C (zh) | 2004-03-17 |
| EP0977875A1 (en) | 2000-02-09 |
| WO1998049328A1 (en) | 1998-11-05 |
| ATE353971T1 (de) | 2007-03-15 |
| EP0977875B1 (en) | 2007-02-14 |
| CN1253591A (zh) | 2000-05-17 |
| JP2001527401A (ja) | 2001-12-25 |
| JP4312834B2 (ja) | 2009-08-12 |
| DK0977875T3 (da) | 2007-06-04 |
| GB9708452D0 (en) | 1997-06-18 |
| AU7057098A (en) | 1998-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60036641T2 (de) | Mutanter apre promoter | |
| DE3883041T2 (de) | Stabile Genamplifizierung in prokaryotischer chromosonaler DNA. | |
| DE3856331T2 (de) | Molekulare Klonierung und Expression von proteolytische Enzyme kodierenden Genen | |
| DE69837086T2 (de) | Verbesserte prokariontische proteinenexpression | |
| DE3486139T2 (de) | Bacillus, der weder Subtilisin noch neutrale Protease ausscheiden kann. | |
| DE69434663T2 (de) | Nukleotidsequenzen zur expressionskontrolle von dns-sequenzen in einer wirtszelle | |
| DE69334006T2 (de) | Dna - amplifikation | |
| DE69434807T2 (de) | Methode und system zur erhöhten produktion von kommerziell wichtigen exoproteinen in gram-positiven bakterien | |
| DE68926333T2 (de) | Bacillus-Stämme | |
| DE69723855T2 (de) | Verfahren zur herstellung von polypeptiden in surfaktinmutanten von bacillus zellen | |
| EP1282716A1 (de) | Verfahren zur herstellung rekombinanter proteine durch gram-negative bakterien | |
| EP0342633B1 (de) | Bacillus thuringiensis Transformation | |
| DE69111456T2 (de) | Eine methode für die schnelle selektion von effizienten sekretionsvektoren. | |
| DE69532646T2 (de) | Verfahren zur herstellung extrazellulärer proteine in bakterien | |
| DE3688282T2 (de) | Erhöhung der Expression von Genen in Mikroorganismen. | |
| DE69026260T2 (de) | Induzierbare Expressionsvektoren | |
| DE68929370T2 (de) | Verfahren zur Selektion und zur stabilen Einschleusung rekombinanter DNA in Milchsäurebakterien | |
| DE3650477T2 (de) | Produktion von Cystinreste enthaltenden aktiven Proteinen | |
| DE69028890T2 (de) | Ergiebige Herstellung von Protease-Mutanten | |
| DE69230825T2 (de) | Genexpression in bazillen | |
| EP1599579B1 (de) | Ein translokationsenzym als selektionsmarker | |
| DE69105188T2 (de) | Asporogener Stamm von Bacillus substilis und seine Verwendung als Wirt in der Herstellung von heterologen Produkten. | |
| DE3850456T2 (de) | Klonierung des isoamylaseenzym kodierenden Gens und seine Verwendung zur Herstellung dieses Enzyms. | |
| DE69928830T2 (de) | Proteinproduktion in gram-positiven mikroorganismen | |
| DE69634853T2 (de) | Ftsy-exprimierende gram-positive mikroorganismen mit verbesserten sekretionseigenschaften |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8381 | Inventor (new situation) |
Inventor name: HARWOOD, ROBERT COLIN, NEWCASTLE UPON TYNE, GB Inventor name: STEPHENSON, KEITH, NEWCASTLE UPON TYNE, GB Inventor name: JORGENSEN, STEEN, DK-2880 BAGSVAERD, DK Inventor name: JENSEN, CHRISTINA, DK-2880 BAGSVAERD, DK Inventor name: KRISTENSEN, TINA, DK-2880 BAGSVAERD, DK |
|
| 8363 | Opposition against the patent | ||
| 8339 | Ceased/non-payment of the annual fee |